ATS (ATS) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
27 Apr, 2026Company overview and business model
Industry leader in automated manufacturing and assembly systems, serving life sciences, consumer products, food & beverage, energy, and transportation sectors.
Employs over 7,000 people across 65 manufacturing facilities and 85 offices globally.
Focuses on custom automation, standard products, digital solutions, and recurring service revenues.
Pursues a value creation strategy of Build, Grow, and Expand, leveraging disciplined acquisitions and innovation.
Selective in market focus, favoring regulated industries where quality and reliability are critical.
Financial performance and metrics
Financial statements prepared in accordance with IFRS and may not be directly comparable to US GAAP.
As of April 24, 2026, qualifying public equity was $3,429,220,738.
98,114,232 common shares outstanding as of April 24, 2026.
Common shares traded on TSX and NYSE, with closing prices of $45.17 (TSX) and US$33.04 (NYSE) on April 24, 2026.
Use of proceeds and capital allocation
Net proceeds from securities offerings will be used as specified in each prospectus supplement; proceeds from secondary offerings go to selling securityholders.
Strategic capital allocation framework aims to drive long-term sustainable shareholder value.
Latest events from ATS
- Board and auditor appointments approved; focus on value creation and growth initiatives.ATS
AGM 2026 - Revenues fell 5.8% and a net loss was posted as cost transformation and margin initiatives began.ATS
Q1 2027 - Margin expansion, portfolio diversification, and disciplined M&A drive future growth.ATS
47th Annual Raymond James Institutional Investor Conference - Life Sciences and digital services drive growth, with strong bookings and expanding recurring revenue.ATS
Citi's Global Industrial Tech and Mobility Conference 2025 - C$3.0B adjusted revenue, strong M&A, and disciplined growth in automation markets.ATS
Investor presentation - Revenue and earnings rose in fiscal 2026, with restructuring driving margin expansion.ATS
Q4 2026 - Record financial results, all resolutions passed, and strategic focus on regulated markets.ATS
AGM 2024 - Q2 revenue fell 17% as transportation slumped, but record life sciences bookings and a $1.8B backlog support growth.ATS
Q2 2025 - Record backlog and EV settlement set the stage for margin and leverage improvement.ATS
Q4 2025